News

Ampersand Capital Partners Gains Recognition as Top Firm in 2025

Ampersand Capital Partners Gains Recognition as Top Firm in 2025

Ampersand Capital Partners Recognized as a Leading Firm

Ampersand Capital Partners, a distinguished growth equity firm with close to 40 years of experience in nurturing leading companies within the healthcare and life sciences sectors, has been honored with the title of a Top Private Equity Firm for the year 2025 by GrowthCap.

Acknowledgement from GrowthCap

Herb Hooper, the Managing Partner of Ampersand, expressed his pride in receiving such recognition. He stated, "We are proud to once again receive recognition from GrowthCap as a Top Private Equity Firm of 2025. Ampersand's focused strategy in healthcare and life sciences has consistently enabled us to identify breakthrough opportunities and scale industry leaders. We are excited to continue partnering with exceptional founders and management teams to enable future innovations across the healthcare ecosystem."

Comprehensive Evaluation Process

GrowthCap's ongoing monitoring of private equity firms involves an assessment of deal activities and performance, distinguishing those with a reliable capability to enhance value for their portfolio companies. Their selections for this year accentuate firms that have maintained a remarkable partnership with companies as they evolve and fortify their market positions. While financial performance is considered, the primary focus rests on a firm's ability to generate sustainable improvements and value consistently.

What Sets Ampersand Apart

Ampersand Capital Partners operates with a unique methodology that blends private equity with operating expertise, facilitating value creation and long-term success alongside management teams of portfolio companies. This strategic approach has enabled Ampersand to contribute to the growth of numerous industry-leading firms across various sectors within healthcare.

About the Firm

Founded in 1988, Ampersand Capital Partners has established itself as a reputable middle-market private equity firm, currently managing approximately $3 billion in assets dedicated to growth-oriented investments in the healthcare sector. With locations in major financial hubs, the firm leverages its extensive knowledge to build lasting relationships and significant value within its portfolio. Their commitment to identifying innovative solutions continues to drive the firm’s success and the success of their partners.

Looking Ahead

The achievements recognized by GrowthCap reflect the ongoing dedication of Ampersand to fostering innovation and growth within the healthcare landscape. As the firm looks to the future, their focus on partnering with exceptional management teams will undoubtedly yield positive outcomes in the healthcare environment.

Continuous Commitment to Healthcare

Across its core sectors, Ampersand remains devoted to enhancing healthcare solutions that improve patient outcomes and operational efficiencies. This commitment not only benefits their portfolio companies but also contributes immensely to the broader healthcare industry.

Frequently Asked Questions

What is Ampersand Capital Partners known for?

Ampersand Capital Partners is recognized for its growth equity investments in the healthcare and life sciences sectors, with a history of successful partnerships.

How long has Ampersand Capital been operating?

The firm has been active since 1988, marking close to 40 years in the private equity landscape.

What does GrowthCap measure in its evaluations?

GrowthCap evaluates firms based on their capabilities in creating and enhancing company value sustainably rather than solely on financial performance.

Where is Ampersand Capital based?

Ampersand Capital has offices in major locations, including Boston and Amsterdam, reflecting its international outreach.

How does Ampersand create value for its portfolio companies?

Through a combination of private equity insights and operational expertise, Ampersand partners closely with management teams to drive growth and innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Updated Category News Views 79

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...

Continue Reading
USDA Loans in Pampa: Clearing Up Misconceptions

Updated Category News Views 72

Understanding USDA Loans in Pampa When it comes to buying a home in Pampa, Texas, there's a lot of chatter about USDA loans, and a fair bit of confusion too. Now, real estate expert Patti Hudson is cutting through the noise and setting the record straight, making sure families know all the facts before diving into the housing market. Not Just for Rural Areas Let's squash...

Continue Reading
CapCut Leads 2026 AI Image Tools for Creatives

Updated Category News Views 29

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

Continue Reading
New Ambulatory Surgery Center in Alabama Breaks Ground

Updated Category News Views 18

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Continue Reading
Liz Parrish's Bold Take on Gene Therapy and Aging

Updated Category News Views 27

A Mother's Quest: From Personal Struggles to Professional Breakthroughs Never underestimate a mother's determination. When Liz Parrish's son was diagnosed with Type 1 diabetes, it sparked a relentless drive in her to find answers beyond conventional medicine. This journey led Parrish, CEO of BioViva Sciences USA Inc., not just into the cutting-edge world of gene therapy,...

Continue Reading
oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

Updated Category News Views 74

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 70

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
Red Robin Faces Board Shakeup and Financial Strategy Shift

Updated Category News Views 49

Turbulence on the Board But Strategic Moves on Track Well, it's not every day you hear about a double departure from Red Robin's board, right on the heels of some big financial reshuffling. Two directors, James C. Pappas and Christopher Martin, decided to abandon ship effective October 23, 2026. Given their ties to JCP Investment and Jumana Capital, this isn't just a...

Continue Reading
Medical Device Manufacturing: $135B Market by 2031

Updated Category News Views 96

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

Continue Reading
UPM Defies Market Challenges: Strong Q3 Cash Flow

Updated Category News Views 30

UPM's Impressive Q3 Performance Amidst Challenges UPM-Kymmene Corporation just dropped their Q3 numbers, and let me tell ya, there's a lot to digest. In the face of some pretty gnarly market conditions—think destocking and those pesky cost inflations—they've managed to pull a rabbit out of the hat with strong cash flow. That's not a small feat, folks; it's a damn...

Continue Reading

Top 5 Most Recently Viewed Articles

TD Cowen Affirms Positive Outlook on Tradeweb Markets Growth

Updated Category News Views 39

TD Cowen Maintains Buy Rating for Tradeweb Markets TD Cowen recently expressed confidence in Tradeweb Markets (NASDAQ: TW), reinforcing its 'Buy' rating and setting a price target of $139.00. This endorsement comes on the heels of Tradeweb's recent release of trading metrics, which exceeded market expectations for September, showcasing robust performance across major...

Continue Reading
Rocket Alumni Solutions Transforms Donor Recognition Landscape

Updated Category News Views 21

Digital Recognition's New Era Donor recognition in educational institutions is getting a digital facelift, and Rocket Alumni Solutions is at the forefront of this transformation. In a world where tech means everything, schools are ditching static plaques for interactive digital displays. The Dynamic Power of Digital This ain't your granddad's donor wall. We're talking...

Continue Reading
EHang's Revolutionary Leap Toward Pilotless Aviation Dominance

Updated Category News Views 126

A New Era in Aviation: EHang's Vision In an industry where aeronautical innovations often hinge on pilot training and rigorous regulatory compliance, China's EHang Holdings Ltd (NASDAQ: EH) is in a league of its own. The Guangzhou-based eVTOL (electric Vertical Take-Off and Landing) manufacturer is paving the way for autonomous flying by operating commercial routes....

Continue Reading
BitMart's Innovative Strategies for Localizing Crypto Services

Updated Category News Views 156

Exploring BitMart's Strategic Localization Playbook In the world of cryptocurrency exchanges, the ability to adapt to cultural nuances and language preferences is paramount. BitMart, a prominent player in this arena, is making headlines with its recent localization initiatives, particularly through its rebranding to “??.” This substantial shift aims to bridge the gap...

Continue Reading